MLH1 and melanoma: As example MLH1 methylation is strongly associated with decreased clinical response and survival in melanoma [18] and decitabine was reported to reverse MLH1 methylation and result in proficient mismatch repair system and sensitizing cancer cells to cytotoxic agents [19].